Biohaven Net Income 2016-2022 | BHVN
Biohaven net income from 2016 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Biohaven Annual Net Income
(Millions of US $) |
| 2021 |
$-847 |
| 2020 |
$-767 |
| 2019 |
$-529 |
| 2018 |
$-241 |
| 2017 |
$-139 |
| 2016 |
$-64 |
| 2015 |
$-10 |
Biohaven Quarterly Net Income
(Millions of US $) |
| 2022-09-30 |
$-69 |
| 2022-06-30 |
$-441 |
| 2022-03-31 |
$-209 |
| 2021-12-31 |
$-317 |
| 2021-09-30 |
$-54 |
| 2021-06-30 |
$-211 |
| 2021-03-31 |
$-265 |
| 2020-12-31 |
$-218 |
| 2020-09-30 |
$-195 |
| 2020-06-30 |
$-181 |
| 2020-03-31 |
$-173 |
| 2019-12-31 |
$-149 |
| 2019-09-30 |
$-106 |
| 2019-06-30 |
$-211 |
| 2019-03-31 |
$-62 |
| 2018-12-31 |
$-55 |
| 2018-09-30 |
$-61 |
| 2018-06-30 |
$-39 |
| 2018-03-31 |
$-85 |
| 2017-12-31 |
$-27 |
| 2017-09-30 |
$-43 |
| 2017-06-30 |
$-46 |
| 2017-03-31 |
$-23 |
| 2016-12-31 |
$-26 |
| 2016-09-30 |
$-28 |
| 2016-06-30 |
$-7 |
| 2016-03-31 |
$-3 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.913B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
